{"id":"W4405374985","doi":"10.1016/j.iotech.2024.100845","title":"102P A real-world study of the efficacy of second-line treatment of unresectable hepatocellular carcinoma after progression on first-line lenvatinib combined with PD-1 inhibitor","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Hepatocellular carcinoma; Medicine; Oncology; Internal medicine; Second line; Line (geometry); First line; Sorafenib","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01377752,0.001078138,0.005956038,0.002700443,0.0004753797,0.002295091,0.001022045,0.002142434,0.006705258],"category_scores_gemma":[0.04118028,0.0007225588,0.01770582,0.003806879,0.0007394961,0.001659617,0.001106472,0.001920259,0.0006352427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001796025,"about_ca_system_score_gemma":0.002167232,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002308175,"about_ca_topic_score_gemma":0.00314002,"domain_scores_codex":[0.9860486,0.007593296,0.003424705,0.001400814,0.001178375,0.0003542123],"domain_scores_gemma":[0.9629764,0.02169759,0.01095594,0.001304279,0.002410021,0.0006556943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"observational","study_design_scores_codex":[0.1379711,0.0009853693,0.04494952,0.2312033,0.5444107,0.0006760793,0.0003685135,0.0008716004,0.00101668,0.0004347085,0.00207144,0.03504097],"study_design_scores_gemma":[0.05439051,0.0168176,0.08578052,0.03332939,0.7956727,0.00091216,0.0004524764,0.0009841886,0.0007580036,0.0005536315,0.01018945,0.0001594019],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2868854,0.6929647,0.001534403,0.001602886,0.0007403679,0.003055639,0.009244036,0.00007692945,0.003895596],"genre_scores_gemma":[0.9467521,0.04642078,0.001315534,0.0009467895,0.0003273381,0.00146398,0.002139227,0.00002348996,0.0006108296],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01377752,"threshold_uncertainty_score":0.0728634,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03585710363949379,"score_gpt":0.2980887263409522,"score_spread":0.2622316227014584,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}